Diabetes Prevention
Supporting research that identifies risk earlier and improves prevention strategies for individuals and populations — because preventing a single case is more powerful than managing a lifetime of disease.
From prevention to cure, KiCares supports six interconnected areas of focus — each chosen for its potential to deliver meaningful, measurable impact for people living with diabetes.

The treatments and technologies that define diabetes care today — from insulin analogs and continuous glucose monitors to islet-cell research and immune-modulating therapies — exist because of decades of sustained research funding.
Yet Type 1 diabetes still has no cure, and millions remain undiagnosed or at risk. Closing that gap requires philanthropic capital that can move faster than traditional grant cycles and reach the high-promise, early-stage science that most needs a champion.
Supporting research that identifies risk earlier and improves prevention strategies for individuals and populations — because preventing a single case is more powerful than managing a lifetime of disease.
Backing innovations — from novel biomarkers to community screening — that enable earlier intervention. Early detection significantly improves long-term outcomes and reduces costly complications.
Funding studies that advance scientific understanding, refine treatment protocols, and elevate the standard of care for both Type 1 and Type 2 diabetes.
Helping move discoveries from the laboratory bench into real-world healthcare solutions, approved therapies, and the hands of clinicians who need them.
Supporting educational programs and community outreach that empower patients, families, and caregivers to live well and advocate effectively.
Investing in next-generation technologies — from regenerative medicine and beta-cell biology to AI-driven discovery and continuous-sensing platforms.
Diabetes drives some of the most serious complications in modern medicine: blindness, kidney failure, heart disease, nerve damage, and amputation. Funded research has already changed what's possible — and continued investment is what will change it again.

Our funding decisions are guided by scientific merit, collaborative potential, and projected patient impact. We partner with leading researchers and institutions to ensure every dollar accelerates the path to better outcomes.